What five Lyme doctors have to say about COVID-19 and their patients
In this webinar, five well known Lyme doctors discuss coronavirus and how it is affecting…
In this webinar, five well known Lyme doctors discuss coronavirus and how it is affecting…
The American Academy of Ophthalmology has alerted its members that pink eye (conjunctivitis) may be…
(Editor’s note: Hydroxychloroquine, known by the brand name Plaquenil, is a drug familiar to many Lyme…
Message from Medicare Medicare has temporarily expanded its coverage of telehealth services in response to COVID-19. Medicare…
By Tracie White, Stanford University For decades, the routine treatment for Lyme disease has been…
Dr. Steven Bock, a Lyme-treating physician, provides information about the coronavirus–and the risk it poses…
The federal Tick-Borne Disease Working Group held two days of meetings in Philadelphia on March…
The federal Tick-Borne Disease Working Group met in Philadelphia on March 3 and 4. Lonnie…
The federal Tick-Borne Disease Working Group met in Philadelphia on March 3 and 4. LymeDisease.org’s…
The Spring 2020 issue of the Lyme Times features four articles about disulfiram. The drug…
End of content
End of content